Antifungal activity of new copper(II) complexes of 2-methylthionicotinate (2-MeSNic) of the composition Cu(2-MeSNic)2(MeNia)(2).4H2O (where MeNia is N-methylnicotinamide), and Cu(2-MeSNic)2(Nia)(2).2H2O (where Nia is nicotinamide) and Cu(2-MeSNic)2L2 (where L is isonicotinamide, iNia, or ethyl nicotinate, EtNic) were tested on various strains of filamentous fungi by the macrodilution method. Most sensitive against copper(II) adducts with bioactive ligands were Rhizopus oryzae and Microsporum gypseum (IC50 1.5-2.3 mmol/L). The adducts with Nia, MeNia and EtNic at 5 mmol/L induced morphological changes in growing hyphae of Botrytis cinerea, mainly their intensive branching attached to release of cytoplasm with partial growth inhibition. Inhibition of sporulation (> 90%) of Alternaria alternata by Cu(2-MeSNic)2.H2O was observed as a change in the color of the colonies. The highest resistance was marked by B. cinerea and Fusarium moniliforme (average IC50 values 4.25 and 3.13 mmol/L, respectively). The presence of all bioactive ligands in copper(II) complexes caused an increase in the inhibition effect against model fungi (except significant inhibition activity of EtNic on R. oryzae).

Department of Biochemistry and Microbiology Faculty of Chemical and Food Technology Slovak University of Technology 812 37 Bratislava Slovakia

Zobrazit více v PubMed

Ceska Slov Farm. 1994 Oct;43(5):240-2 PubMed

Folia Microbiol (Praha). 1996;41(6):473-6 PubMed

Folia Microbiol (Praha). 2001;46(5):379-84 PubMed

Ceska Slov Farm. 1998 Jul;47(4):166-9 PubMed

Folia Microbiol (Praha). 2000;45(4):305-9 PubMed

Folia Microbiol (Praha). 2000;45(6):573-5 PubMed

Chemosphere. 2001 Jul;44(3):313-9 PubMed

Cesk Farm. 1992 Mar;41(2):40-6 PubMed

Ga(III) pyridinecarboxylate complexes: potential analogues of the second generation of therapeutic Ga(III) complexes?

Antimicrobial and Anticancer Application of Silver(I) Dipeptide Complexes

Antimicrobial activity of ZnII, CdII, and HgII complexes of 1,2-bis-[2-(5-R)-1H-benzimidazolyl]-1,2-ethanediols and 1,4-bis-[2-(5-R)-1H-benzimidazolyl]-1,2,3,4-butanetetraols